Order Article Reprints

Muthu S, Jeyaraman M, Kotner MB, Jeyaraman N, Rajendran RL, Sharma S, Khanna M, Rajendran SNS, Oh JM, Gangadaran P, et al. Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective. Bioengineering. 2022; 9(3):111. https://doi.org/10.3390/bioengineering9030111

Muthu, Sathish, Madhan Jeyaraman, Moinuddin Basha Kotner, Naveen Jeyaraman, Ramya Lakshmi Rajendran, Shilpa Sharma, Manish Khanna, Sree Naga Sowndary Rajendran, Ji Min Oh, Prakash Gangadaran, and et al. 2022. "Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective" Bioengineering 9, no. 3: 111. https://doi.org/10.3390/bioengineering9030111

Muthu, S., Jeyaraman, M., Kotner, M. B., Jeyaraman, N., Rajendran, R. L., Sharma, S., Khanna, M., Rajendran, S. N. S., Oh, J. M., Gangadaran, P., & Ahn, B.-C. (2022). Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective. Bioengineering, 9(3), 111. https://doi.org/10.3390/bioengineering9030111